Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04644952

Conditions

Lung Carcinoma

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Electronic Health Record Review

Study Details

Brief summary:

This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.

Conditions

Lung Carcinoma

Study ID

NCT04644952

Start date

Sep 15, 2020

Status verified date

Mar, 2026

Completion date

Apr 30, 2027

Anticipated

Primary completion date

Apr 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who underwent a lung resection from 2004 to 2019

Study Design

Enrollment

600 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (medical record review)

Patients' medical records are reviewed retrospectively.

Interventions

Electronic Health Record Review

Review of medical records

Primary outcome measure

  • Rate of change in robotic segmentectomies [ Time Frame: Up to 2 years ]
  • Rate of typical and atypical segmentectomies [ Time Frame: Up to 2 years ]
  • Differences in robotic versus other types of resections such as open and video-assisted thoracic surgery [ Time Frame: Up to 2 years ]

Central Contacts and Locations

Central contacts

David C. Rice

713-563-9153drice@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

David C. Rice

713-563-9153

Principal Investigator:

David C. Rice

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Mar 5, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-03-05.